# A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941

> **NCT01187186** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 16 (actual)

## Conditions studied

- Liver Disease

## Interventions

- **DRUG:** ASP1941

## Key facts

- **NCT ID:** NCT01187186
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2010-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01187186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01187186, "A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01187186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*